facebook
twitter
rss
account
search
search
 

Panel to consider new 'morning-after pill'

June 8, 2010 at 9:23 AM   |   Comments

WASHINGTON, June 8 (UPI) -- A "morning-after pill" that reportedly is effective for five days after sex is being considered for approval in the United States, officials said.

A Food and Drug Administration advisory panel is to meet June 17 to consider whether the agency should approve ulipristal acetate for sale in U.S. markets.

HRA Pharma, of Paris, already sells ulipristal acetate in 21 European countries, where it is marketed under the name ellaOne.

The only "morning-after pill" currently in the United States is Plan B, the brand name for levonorgestrel.

Plan B inhibits ovulation for up to 72 hours after unprotected sex, but becomes less effective over time, USA Today reported Tuesday. Ulipristal is consistently effective for up to 120 hours, or five days, after unprotected sec, HRA Pharma said.

Ulipristal and levonorgestrel work by inhibiting ovulation, company officials said.

© 2010 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Recommended UPI Stories
Most Popular
1
Fewer prescription pill overdoses in medical marijuana states
2
New data shows Melbourne is most well-rested city in the world
3
New research details rare cancer that killed Bob Marley
4
Poll: 26 percent of Americans believe they will get Ebola
5
Daughters more likely than sons to care for elder parents
Trending News
Video
x
Feedback